ARDX
Ardelyx Inc
Price:  
4.70 
USD
Volume:  
4,159,280.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Ardelyx EV/EBITDA

-153.9%
Upside

As of 2025-07-11, the EV/EBITDA ratio of Ardelyx Inc (ARDX) is -34.89. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Ardelyx's latest enterprise value is 1,245.02 mil USD. Ardelyx's TTM EBITDA according to its financial statements is -35.69 mil USD. Dividing these 2 quantities gives us the above Ardelyx EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 8.4x - 13.1x 10.8x
Forward P/E multiples 12.1x - 20.8x 16.4x
Fair Price (2.31) - (2.46) (2.53)
Upside -149.1% - -152.3% -153.9%
4.70 USD
Stock Price
(2.53) USD
Fair Price

Ardelyx EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-07-09 -34.22
2025-07-08 -33.41
2025-07-07 -32.54
2025-07-03 -32.00
2025-07-02 -31.47
2025-07-01 -29.52
2025-06-30 -29.66
2025-06-27 -28.12
2025-06-26 -28.08
2025-06-25 -27.71
2025-06-24 -28.05
2025-06-23 -27.71
2025-06-20 -27.24
2025-06-18 -27.58
2025-06-17 -27.18
2025-06-16 -27.91
2025-06-13 -27.51
2025-06-12 -28.32
2025-06-11 -28.18
2025-06-10 -28.45
2025-06-09 -28.58
2025-06-06 -28.05
2025-06-05 -27.78
2025-06-04 -28.12
2025-06-03 -29.72
2025-06-02 -29.19
2025-05-30 -27.98
2025-05-29 -30.40
2025-05-28 -29.59
2025-05-27 -29.99
2025-05-23 -29.99
2025-05-22 -29.93
2025-05-21 -30.13
2025-05-20 -31.40
2025-05-19 -30.60
2025-05-16 -29.39
2025-05-15 -26.04
2025-05-14 -25.37
2025-05-13 -26.10
2025-05-12 -27.04
2025-05-09 -27.65
2025-05-08 -27.78
2025-05-07 -28.18
2025-05-06 -29.86
2025-05-05 -28.42
2025-05-02 -31.07
2025-05-01 -40.05
2025-04-30 -40.28
2025-04-29 -39.92
2025-04-28 -39.24